Elevance Health, Inc. (ELV) Stock Analysis

Elevance Health, based in Indianapolis, Indiana, is one of the largest managed care providers in the United States healthcare sector. The company sells commercial health insurance, Medicare, Medicaid, and specialized dental and vision plans to individuals, employers, and government programs. Beyond core insurance under its Anthem Blue Cross Blue Shield and Wellpoint brands, it operates pharmacy benefit management and clinical care services through CarelonRx and Carelon Services. In total, the business serves roughly 45.7 million medical members across the country.

Elevance operates as a dominant market leader in healthcare plans, running exclusive Blue Cross Blue Shield franchises across 14 states. That regional scale gives the company solid pricing power and deeply entrenched employer relationships that competitors like UnitedHealth Group and CVS Health struggle to dislodge. The main headwind is heavy exposure to government-sponsored healthcare, where state-level Medicaid eligibility redeterminations cut into enrollment numbers. Elevance wins when commercial enrollment stays steady, but policy shifts and medical cost fluctuations in its government books remain direct threats to margin stability.

The business is actively pivoting from a traditional health insurer into an integrated health services provider, marked by its June 2022 rebrand from Anthem. Total operating revenue climbed roughly 3% to $175.2 billion in 2024, supported by double-digit expansion in its Carelon services arm. Carelon delivered $53.9 billion in operating revenue for 2024, up 12% year-over-year, demonstrating that in-house pharmacy services and clinical data analytics are cushioning core insurance attrition. Elevance is no longer just collecting premiums; it is capturing more revenue per member by treating healthcare services as its main growth engine.